ImmunityBio, Inc. (NASDAQ: IBRX) today announced an update on the status of enrollment in its randomized registrational trial ...
The collaboration seeks to address this gap by transitioning organisations from limited experimentation to enterprise-wide ...
The BCG compression tee sees me through every type of workout: 400-meter repeats, tempo runs, hill sprints, as well as ...
ImmunityBio (IBRX) stock jumps after the FDA meeting on the company's plans to seek label expansion for bladder cancer therapy Anktiva. Read more here.
I was born and raised in India. On the day I was born, I am told I got my first jab, a vaccine called BCG (bacille Calmette-Guerin). Kids born in India today still get this vaccine. This century-old ...
Partnership accelerates real-world generative AI value creation in biopharma and medtech industries.SAN FRANCISCO--(BUSINESS ...
Up to $100 million in additional loan proceeds provide additional financial flexibility to advance detalimogene development ...
BCG notes that shopping has become the third most common use case for GenAI, extending beyond big-ticket items to everyday purchases such as groceries. Overall, the use of GenAI for shopping-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback